Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
JAK and MPL mutations in myeloid malignancies
Ayalew Tefferi
Hematology
Research output
:
Contribution to journal
›
Review article
›
peer-review
62
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'JAK and MPL mutations in myeloid malignancies'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Mutation
100%
Essential Thrombocythemia
68%
Polycythemia Vera
66%
Primary Myelofibrosis
63%
Neoplasms
57%
Transducers
52%
Congenital amegakaryocytic thrombocytopenia
48%
Protein-Tyrosine Kinases
46%
Leukemia, Megakaryoblastic, Acute
39%
TYK2 Kinase
38%
Thrombopoietin Receptors
38%
Myelopoiesis
36%
Gain of Function Mutation
33%
Thrombocytosis
33%
Severe Combined Immunodeficiency
32%
Cytokine Receptors
30%
Genetic Association Studies
27%
Myeloid Cells
26%
Acute Myeloid Leukemia
24%
Exons
21%
Cell Differentiation
20%
Alleles
18%
Cell Proliferation
16%